These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1897559)

  • 1. Fluconazole: a new triazole antifungal agent.
    Morrow JD
    Am J Med Sci; 1991 Aug; 302(2):129-32. PubMed ID: 1897559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.
    Goa KL; Barradell LB
    Drugs; 1995 Oct; 50(4):658-90. PubMed ID: 8536553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.
    Grant SM; Clissold SP
    Drugs; 1990 Jun; 39(6):877-916. PubMed ID: 2196167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of candidiasis and cryptococcosis in AIDS].
    Just-Nübling G
    Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current progress in antifungal therapy: the value of fluconazole].
    Meunier F
    Rev Med Brux; 1990 Sep; 11(7):278-82. PubMed ID: 2218209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole: a new antifungal agent.
    Kowalsky SF; Dixon DM
    Clin Pharm; 1991 Mar; 10(3):179-94. PubMed ID: 2040125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole therapy for experimental cryptococcosis and candidiasis in the rabbit.
    Perfect JR
    Rev Infect Dis; 1990; 12 Suppl 3():S299-302. PubMed ID: 2184508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral azole drugs as systemic antifungal therapy.
    Como JA; Dismukes WE
    N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale multicentre study of fluconazole in the treatment of hospitalised patients with fungal infections. Multicentre European Study Group.
    Troke PF
    Eur J Clin Microbiol Infect Dis; 1997 Apr; 16(4):287-95. PubMed ID: 9177962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High-dose therapy with fluconazole > or = 800 mg/day. Review].
    Penk A; Pittrow L
    Mycoses; 1997; 40 Suppl 1():33-42. PubMed ID: 9417511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
    Debruyne D
    Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304.
    Perfect JR; Wright KA; Hobbs MM; Durack DT
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1735-40. PubMed ID: 2556078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose therapy with fluconazole > or = 800 mg day-1.
    Duswald KH; Penk A; Pittrow L
    Mycoses; 1997 Nov; 40(7-8):267-77. PubMed ID: 9476509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of systemic mycoses in immunodeficiency].
    Just-Nübling G; Stille W
    Immun Infekt; 1991 Aug; 19(4):116-20. PubMed ID: 1937558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole.
    Med Lett Drugs Ther; 1990 May; 32(818):50-2. PubMed ID: 2185400
    [No Abstract]   [Full Text] [Related]  

  • 17. [Collection of cases in relation to clinical trials of fluconazole in Germany].
    Krisch H; Sarnow E
    Mycoses; 1990; 33 Suppl 1():14-8. PubMed ID: 2101859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of fluconazole].
    Oka S; Tokitsu M; Mori H; Nakata H; Goto M; Goto H; Shimada K
    Jpn J Antibiot; 1989 Jan; 42(1):31-9. PubMed ID: 2540365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antifungal combination therapy in invasive fungal infections].
    Gellen-Dautremer J; Lanternier F; Dannaoui E; Lortholary O
    Rev Med Interne; 2010 Jan; 31(1):72-81. PubMed ID: 19767130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole for life-threatening fungal infections in patients who cannot be treated with conventional antifungal agents.
    Robinson PA; Knirsch AK; Joseph JA
    Rev Infect Dis; 1990; 12 Suppl 3():S349-63. PubMed ID: 2330489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.